Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-17

FDA Approved: GABAPENTIN — Supplemental Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for gabapentin filed by Creekwood Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)